{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T04:38:55Z","timestamp":1792211935137,"version":"4.4.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["IIR 16-239"],"award-info":[{"award-number":["IIR 16-239"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["RCS 00-001"],"award-info":[{"award-number":["RCS 00-001"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["RCS 14-232"],"award-info":[{"award-number":["RCS 14-232"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K23 DA049953"],"award-info":[{"award-number":["K23 DA049953"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Justice"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The Veterans Health Administration has made strides to improve access to medications for opioid use disorder overall. However, quality improvement methods to assess treatment gaps may not sufficiently detect differences in medication access by intersecting patient factors, which may have multiplicative rather than additive effects. This study aimed to determine whether race\/ethnicity and legal involvement interact in receipt of medications for opioid use disorder among Veterans Health Administration patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Using national electronic health record data from Fiscal Years 2021\u20132022, we examined the receipt of medications for opioid use disorder among veterans diagnosed with opioid use disorder who received healthcare at Veterans Health Administration facilities (<jats:italic>n<\/jats:italic>\u2009=\u200965,883). We conducted a mixed effects multivariable logistic regression model to examine an interaction effect of race\/ethnicity and legal involvement with receipt of any medications for opioid use disorder, both unadjusted and adjusted for patient and facility characteristics.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In an adjusted logistic regression model, the interaction effect indicated that non-Hispanic Black veterans with legal involvement had the lowest odds of medications for opioid use disorder receipt compared to non-Hispanic White veterans without legal involvement (adjusted odds ratio\u2009=\u20090.67, 95% confidence interval\u2009=\u20090.59\u20130.77, <jats:italic>p<\/jats:italic>\u2009&lt;.0001). Non-Hispanic American Indian\/Alaska Native patients without legal involvement (adjusted odds ratio\u2009=\u20090.85, 95% confidence interval\u2009=\u20090.73\u20130.99, <jats:italic>p<\/jats:italic>\u2009=.04) also had lower odds of receipt of medications for opioid use disorder compared to non-Hispanic White patients without legal involvement. Non-Hispanic White veterans with legal involvement (adjusted odds ratio\u2009=\u20091.07, 95% confidence interval\u2009=\u20091.01\u20131.14, <jats:italic>p<\/jats:italic>\u2009=.03) had higher odds of receipt of medications for opioid use disorder compared to non-Hispanic White patients without legal involvement.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Veterans Health Administration quality improvement efforts should monitor interacting racial and legal status factors and understand and address patient, clinical, and regulatory barriers to medications for opioid use disorder among Black veterans with legal involvement.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40352-025-00336-6","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T12:36:15Z","timestamp":1745930175000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Receipt of medications for opioid use disorders among veterans by race\/ethnicity and legal involvement: an observational study of electronic health records"],"prefix":"10.1186","volume":"13","author":[{"given":"Andrea K.","family":"Finlay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Pivovarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengfei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Timko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid A.","family":"Binswanger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Smelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmeline","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex H. S.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"issue":"6","key":"336_CR1","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1377\/hlthaff.2020.02261","volume":"40","author":"B Andraka-Christou","year":"2021","unstructured":"Andraka-Christou, B. (2021). Addressing Racial and ethnic disparities in the use of medications for opioid use disorder. Health Affairs, 40(6), 920\u2013927. https:\/\/doi.org\/10.1377\/hlthaff.2020.02261","journal-title":"Health Affairs"},{"key":"336_CR2","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jsat.2019.06.011","volume":"104","author":"B Andraka-Christou","year":"2019","unstructured":"Andraka-Christou, B., Gabriel, M., Madeira, J., & Silverman, R. D. (2019). Court personnel attitudes towards medication-assisted treatment: A state-wide survey. Journal of Substance Abuse Treatment, 104, 72\u201382. https:\/\/doi.org\/10.1016\/j.jsat.2019.06.011","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"336_CR3","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1177\/29767342241273417","volume":"46","author":"J Berk","year":"2025","unstructured":"Berk, J., Brar, J., Hoadley, A., & Martin, R. (2025). Racial differences in medications for opioid use disorder initiation in a carceral setting. Substance Use & Addiction Journal, 46(1), 64\u201371. https:\/\/doi.org\/10.1177\/29767342241273417","journal-title":"Substance Use & Addiction Journal"},{"issue":"1","key":"336_CR4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1037\/a0029652","volume":"10","author":"JH Blue-Howells","year":"2013","unstructured":"Blue-Howells, J. H., Clark, S. C., van den Berk-Clark, C., & McGuire, J. F. (2013). The U.S. Department of veterans affairs veterans justice programs and the sequential intercept model: Case examples in National dissemination of intervention for justice-involved veterans. Psychological Services, 10(1), 48\u201353. https:\/\/doi.org\/10.1037\/a0029652","journal-title":"Psychological Services"},{"issue":"2","key":"336_CR5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1377\/hlthaff.2021.01394","volume":"41","author":"PA Braveman","year":"2022","unstructured":"Braveman, P. A., Arkin, E., Proctor, D., Kauh, T., & Holm, N. (2022). Systemic and structural racism: Definitions, examples, health damages, and approaches to dismantling. Health Affairs, 41(2), 171\u2013178. https:\/\/doi.org\/10.1377\/hlthaff.2021.01394","journal-title":"Health Affairs"},{"issue":"Suppl 1","key":"336_CR6","doi-asserted-by":"publisher","first-page":"100485","DOI":"10.1016\/j.hjdsi.2020.100485","volume":"8","author":"KH Burkitt","year":"2021","unstructured":"Burkitt, K. H., Rodriguez, K. L., Mor, M. K., Fine, M. J., Clark, W. J., Macpherson, D. S., Mannozzi, C. M., Muldoon, M. F., Long, J. A., & Hausmann, L. R. M. (2021). Evaluation of a collaborative VA network initiative to reduce Racial disparities in blood pressure control among veterans with severe hypertension. Healthcare, 8(Suppl 1), 100485. https:\/\/doi.org\/10.1016\/j.hjdsi.2020.100485","journal-title":"Healthcare"},{"key":"336_CR7","unstructured":"Center for Medicaid and CHIP Services, Centers for Medicare & Medicaid Services (2022). Core set of adult health care quality measures for Medicaid: Technical specifications and resource manual for federal Fiscal Year 2022 reporting. Authors. https:\/\/www.medicaid.gov\/medicaid\/quality-of-care\/downloads\/medicaid-adult-core-set-manual.pdf?t=1656605214"},{"issue":"9","key":"336_CR8","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1037\/hea0000368","volume":"35","author":"AG Cuevas","year":"2016","unstructured":"Cuevas, A. G., O\u2019Brien, K., & Saha, S. (2016). African American experiences in healthcare: I always feel like i\u2019m getting skipped over. Health Psychology, 35(9), 987\u2013995. https:\/\/doi.org\/10.1037\/hea0000368","journal-title":"Health Psychology"},{"key":"336_CR9","unstructured":"Department of Veterans Affairs & Department of Defense. (2021). VA\/DoD clinical practice guideline for the management of substance use disorders. Authors."},{"issue":"4","key":"336_CR10","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/ajhp\/zxaa405","volume":"78","author":"BM DeRonne","year":"2021","unstructured":"DeRonne, B. M., Wong, K. R., Schultz, E., Jones, E., & Krebs, E. E. (2021). Implementation of a pharmacist care manager model to expand availability of medications for opioid use disorder. American Journal of Health-System Pharmacy, 78(4), 354\u2013359. https:\/\/doi.org\/10.1093\/ajhp\/zxaa405","journal-title":"American Journal of Health-System Pharmacy"},{"issue":"6","key":"336_CR11","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","volume":"45","author":"RA Deyo","year":"1992","unstructured":"Deyo, R. A., Cherkin, D. C., & Ciol, M. A. (1992). Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. Journal of Clinical Epidemiology, 45(6), 613\u2013619.","journal-title":"Journal of Clinical Epidemiology"},{"key":"336_CR12","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.drugalcdep.2016.01.013","volume":"160","author":"AK Finlay","year":"2016","unstructured":"Finlay, A. K., Harris, A. H. S., Rosenthal, J., Blue-Howells, J., Clark, S., McGuire, J., Timko, C., Frayne, S. M., Smelson, D., Oliva, E., & Binswanger, I. (2016a). Receipt of pharmacotherapy for opioid use disorder by justice-involved U.S. Veterans health administration patients. Drug and Alcohol Dependence, 160, 222\u2013226. https:\/\/doi.org\/10.1016\/j.drugalcdep.2016.01.013","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"336_CR15","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1177\/0887403414562601","volume":"27","author":"AK Finlay","year":"2016","unstructured":"Finlay, A. K., Smelson, D., Sawh, L., McGuire, J., Rosenthal, J., Blue-Howells, J., Timko, C., Binswanger, I., Frayne, S. M., Blodgett, J. C., Bowe, T., Clark, S. C., & Harris, A. H. S. (2016b). U.S. Department of veterans affairs veterans justice outreach program: Connecting justice-involved veterans with mental health and substance use disorder treatment. Criminal Justice Policy Review, 27(2), 203\u2013222. https:\/\/doi.org\/10.1177\/0887403414562601","journal-title":"Criminal Justice Policy Review"},{"issue":"2","key":"336_CR13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/ADM.0000000000000719","volume":"15","author":"AK Finlay","year":"2021","unstructured":"Finlay, A. K., Harris, A. H. S., Timko, C., Yu, M., Smelson, D., Stimmel, M., & Binswanger, I. A. (2021). Disparities in access to medications for opioid use disorder in the veterans health administration. Journal of Addiction Medicine, 15(2), 143\u2013149. https:\/\/doi.org\/10.1097\/ADM.0000000000000719","journal-title":"Journal of Addiction Medicine"},{"issue":"1","key":"336_CR14","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1016\/j.amepre.2021.06.014","volume":"62","author":"AK Finlay","year":"2022","unstructured":"Finlay, A. K., Palframan, K. M., Stimmel, M., & McCarthy, J. F. (2022). Legal system involvement and opioid-related overdose mortality in U.S. Department of veterans affairs patients. American Journal of Preventive Medicine, 62(1), e29\u2013e37. https:\/\/doi.org\/10.1016\/j.amepre.2021.06.014","journal-title":"American Journal of Preventive Medicine"},{"issue":"1","key":"336_CR16","doi-asserted-by":"publisher","first-page":"2355566","DOI":"10.1080\/07853890.2024.2355566","volume":"56","author":"A Giraldo","year":"2024","unstructured":"Giraldo, A., Shah, P., Zerbo, E., & Nyaku, A. N. (2024). The role of recovery peer navigators in retention in outpatient buprenorphine treatment: A retrospective cohort study. Annals of Medicine, 56(1), 2355566. https:\/\/doi.org\/10.1080\/07853890.2024.2355566","journal-title":"Annals of Medicine"},{"issue":"14","key":"336_CR17","doi-asserted-by":"publisher","first-page":"3594","DOI":"10.1007\/s11606-021-07274-7","volume":"37","author":"HJ Hagedorn","year":"2022","unstructured":"Hagedorn, H. J., Gustavson, A. M., Ackland, P. E., Bangerter, A., Bounthavong, M., Clothier, B., Harris, A. H. S., Kenny, M. E., Noorbaloochi, S., Salameh, H. A., & Gordon, A. J. (2022). Advancing Pharmacological treatments for opioid use disorder (ADaPT-OUD): An implementation trial in eight veterans health administration facilities. Journal of General Internal Medicine, 37(14), 3594\u20133602. https:\/\/doi.org\/10.1007\/s11606-021-07274-7","journal-title":"Journal of General Internal Medicine"},{"issue":"9","key":"336_CR18","doi-asserted-by":"publisher","first-page":"e2232314","DOI":"10.1001\/jamanetworkopen.2022.32314","volume":"5","author":"B Han","year":"2022","unstructured":"Han, B., Einstein, E. B., Jones, C. M., Cotto, J., Compton, W. M., & Volkow, N. D. (2022). Racial and ethnic disparities in drug overdose deaths in the US during the COVID-19 pandemic. JAMA Network Open, 5(9), e2232314. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.32314","journal-title":"JAMA Network Open"},{"key":"336_CR19","doi-asserted-by":"publisher","unstructured":"Hansen, H. B., & Roberts, S. K. (2012). Two tiers of biomedicalization: Methadone, buprenorphine, and the racial politics of addiction treatment. In J. Netherland (Ed.), Critical perspectives on addiction14, pp. 79\u2013102). Emerald Group Publishing Limited. https:\/\/doi.org\/10.1108\/S1057-6290(2012)0000014008","DOI":"10.1108\/S1057-6290(2012)0000014008"},{"issue":"3","key":"336_CR20","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1097\/ADM.0000000000000203","volume":"10","author":"AHS Harris","year":"2016","unstructured":"Harris, A. H. S., Weisner, C. M., Chalk, M., Capoccia, V., Chen, C., & Thomas, C. P. (2016). Specifying and pilot testing quality measures for the American society of addiction medicine\u2019s standards of care. Journal of Addiction Medicine, 10(3), 148\u2013155. https:\/\/doi.org\/10.1097\/ADM.0000000000000203","journal-title":"Journal of Addiction Medicine"},{"key":"336_CR21","first-page":"5","volume":"I","author":"T Ho","year":"2018","unstructured":"Ho, T., Carey, S. M., & Malsch, A. M. (2018). Racial and gender disparities in treatment courts: Do they exist and is there anything we can do to change them? Journal for Advancing Justice, I, 5\u201334.","journal-title":"Journal for Advancing Justice"},{"key":"336_CR22","doi-asserted-by":"publisher","first-page":"108918","DOI":"10.1016\/j.jsat.2022.108918","volume":"144","author":"JM Husain","year":"2023","unstructured":"Husain, J. M., Cromartie, D., Fitzelle-Jones, E., Brochier, A., Borba, C. P. C., & Montalvo, C. (2023). A qualitative analysis of barriers to opioid agonist treatment for Racial\/ethnic minoritized populations. Journal of Substance Abuse Treatment, 144, 108918. https:\/\/doi.org\/10.1016\/j.jsat.2022.108918","journal-title":"Journal of Substance Abuse Treatment"},{"key":"336_CR23","doi-asserted-by":"publisher","unstructured":"Jalal, H., Buchanich, J. M., Roberts, M. S., Balmert, L. C., Zhang, K., & Burke, D. S. (2018). Changing dynamics of the drug overdose epidemic in the united States from 1979 through 2016. Science, 361(6408). https:\/\/doi.org\/10.1126\/science.aau1184","DOI":"10.1126\/science.aau1184"},{"issue":"2","key":"336_CR24","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1177\/1073110518782949","volume":"46","author":"K James","year":"2018","unstructured":"James, K., & Jordan, A. (2018). The opioid crisis in black communities. Journal of Law Medicine & Ethics, 46(2), 404\u2013421. https:\/\/doi.org\/10.1177\/1073110518782949","journal-title":"Journal of Law Medicine & Ethics"},{"issue":"2","key":"336_CR25","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jnma.2016.04.002","volume":"108","author":"CJ King","year":"2016","unstructured":"King, C. J., & Redwood, Y. (2016). The health care institution, population health and black lives. Journal of the National Medical Association, 108(2), 131\u2013136. https:\/\/doi.org\/10.1016\/j.jnma.2016.04.002","journal-title":"Journal of the National Medical Association"},{"key":"336_CR26","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1080\/00380237.2009.10571347","volume":"42","author":"HK Knudsen","year":"2009","unstructured":"Knudsen, H. K., & Roman, P. M. (2009). Racial and ethnic composition as a correlate of medication availability within addiction treatment organizations. Sociological Focus, 42, 133\u2013151.","journal-title":"Sociological Focus"},{"issue":"9","key":"336_CR27","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1001\/jamapsychiatry.2019.0876","volume":"76","author":"PA Lagisetty","year":"2019","unstructured":"Lagisetty, P. A., Ross, R., Bohnert, A., Clay, M., & Maust, D. T. (2019). Buprenorphine treatment divide by race\/ethnicity and payment. JAMA Psychiatry, 76(9), 979\u2013981. https:\/\/doi.org\/10.1001\/jamapsychiatry.2019.0876","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"336_CR28","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.amepre.2019.01.016","volume":"57","author":"LA Lin","year":"2019","unstructured":"Lin, L. A., Peltzman, T., McCarthy, J. F., Oliva, E. M., Trafton, J. A., & Bohnert, A. S. B. (2019). Changing trends in opioid overdose deaths and prescription opioid receipt among veterans. American Journal of Preventive Medicine, 57(1), 106\u2013110. https:\/\/doi.org\/10.1016\/j.amepre.2019.01.016","journal-title":"American Journal of Preventive Medicine"},{"issue":"3","key":"336_CR29","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/ADM.0000000000001104","volume":"17","author":"TL Mark","year":"2023","unstructured":"Mark, T. L., Goode, L. S. A., McMurtrie, G., Weinstein, L., & Perry, R. J. (2023). Improving research on Racial disparities in access to medications to treat opioid use disorders. Journal of Addiction Medicine, 17(3), 249\u2013257. https:\/\/doi.org\/10.1097\/ADM.0000000000001104","journal-title":"Journal of Addiction Medicine"},{"issue":"8","key":"336_CR30","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1111\/add.13779","volume":"112","author":"J Marsden","year":"2017","unstructured":"Marsden, J., Stillwell, G., Jones, H., Cooper, A., Eastwood, B., Farrell, M., Lowden, T., Maddalena, N., Metcalfe, C., Shaw, J., & Hickman, M. (2017). Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A National prospective observational study in England. Addiction, 112(8), 1408\u20131418. https:\/\/doi.org\/10.1111\/add.13779","journal-title":"Addiction"},{"issue":"6","key":"336_CR31","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.2105\/AJPH.2013.301222","volume":"103","author":"N Nicosia","year":"2013","unstructured":"Nicosia, N., Macdonald, J. M., & Arkes, J. (2013). Disparities in criminal court referrals to drug treatment and prison for minority men. American Journal of Public Health, 103(6), e77\u201384. https:\/\/doi.org\/10.2105\/AJPH.2013.301222","journal-title":"American Journal of Public Health"},{"issue":"3\u20134","key":"336_CR32","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1111\/ajes.12241","volume":"77","author":"B Pettit","year":"2018","unstructured":"Pettit, B., & Gutierrez, C. (2018). Mass incarceration and Racial inequality. The American Journal of Economics and Sociology, 77(3\u20134), 1153\u20131182. https:\/\/doi.org\/10.1111\/ajes.12241","journal-title":"The American Journal of Economics and Sociology"},{"issue":"2","key":"336_CR33","doi-asserted-by":"publisher","first-page":"e0228755","DOI":"10.1371\/journal.pone.0228755","volume":"15","author":"G Pro","year":"2020","unstructured":"Pro, G., & Zaller, N. (2020). Interaction effects in the association between methadone maintenance therapy and experiences of Racial discrimination in U.S. Healthcare settings. PLoS One, 15(2), e0228755. https:\/\/doi.org\/10.1371\/journal.pone.0228755","journal-title":"PLoS One"},{"key":"336_CR34","unstructured":"Ratcliffe, M., Burd, C., Holder, K., & Fields, A. (2016). Defining rural at the U.S. Census Bureau (ACSGEO-1). https:\/\/www.census.gov\/library\/publications\/2016\/acs\/acsgeo-1.html"},{"issue":"10","key":"336_CR35","doi-asserted-by":"publisher","first-page":"e2436612","DOI":"10.1001\/jamanetworkopen.2024.36612","volume":"7","author":"RK Ross","year":"2024","unstructured":"Ross, R. K., Inose, S., Shulman, M., Nunes, E. V., Zalla, L. C., Burlew, A. K., & Rudolph, K. E. (2024). Variation in opioid agonist dosing in clinical trials by race and ethnicity. JAMA Network Open, 7(10), e2436612. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.36612","journal-title":"JAMA Network Open"},{"issue":"5","key":"336_CR36","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1007\/s11606-008-0521-4","volume":"23","author":"S Saha","year":"2008","unstructured":"Saha, S., Freeman, M., Toure, J., Tippens, K. M., Weeks, C., & Ibrahim, S. (2008). Racial and ethnic disparities in the VA health care system: A systematic review. Journal of General Internal Medicine, 23(5), 654\u2013671. https:\/\/doi.org\/10.1007\/s11606-008-0521-4","journal-title":"Journal of General Internal Medicine"},{"issue":"1_suppl","key":"336_CR37","doi-asserted-by":"publisher","first-page":"24S","DOI":"10.1177\/0033354918793627","volume":"133","author":"B Saloner","year":"2018","unstructured":"Saloner, B., McGinty, E. E., Beletsky, L., Bluthenthal, R., Beyrer, C., Botticelli, M., & Sherman, S. G. (2018). A public health strategy for the opioid crisis. Public Health Reports, 133(1_suppl), 24S\u201334S. https:\/\/doi.org\/10.1177\/0033354918793627","journal-title":"Public Health Reports"},{"key":"336_CR38","unstructured":"SAS Institute Inc. (2013). SAS\/ACCESS\u00ae9.4 Interface to ADABAS: Reference. [Computer software]. SAS Institute Inc."},{"issue":"1","key":"336_CR39","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40352-021-00143-9","volume":"9","author":"CK Scott","year":"2021","unstructured":"Scott, C. K., Dennis, M. L., Grella, C. E., Mischel, A. F., & Carnevale, J. (2021). The impact of the opioid crisis on U.S. State prison systems. Health Justice, 9(1), 17. https:\/\/doi.org\/10.1186\/s40352-021-00143-9","journal-title":"Health Justice"},{"issue":"6","key":"336_CR40","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1007\/s11606-022-07812-x","volume":"38","author":"C Sufrin","year":"2023","unstructured":"Sufrin, C., Kramer, C., Terplan, M., Fiscella, K., Olson, S., Voegtline, K., & Latkin, C. (2023). Availability of medications for opioid use disorder in U.S. Jails. Journal of General Internal Medicine, 38(6), 1573\u20131575. https:\/\/doi.org\/10.1007\/s11606-022-07812-x","journal-title":"Journal of General Internal Medicine"},{"key":"336_CR41","unstructured":"The Commonwealth of Massachusetts. (2024). Outcomes of the medications for opioid use disorder (MOUD) in correctional facilities pilot program. Department of Public Health, Executive Office of Health and Human Services. https:\/\/www.mass.gov\/doc\/chapter-208-2024-legislative-report\/download The Commonwealth of Massachusetts."},{"issue":"11","key":"336_CR42","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1007\/s00127-013-0677-z","volume":"48","author":"J Tsai","year":"2013","unstructured":"Tsai, J., Rosenheck, R. A., Kasprow, W. J., & McGuire, J. F. (2013). Risk of incarceration and clinical characteristics of incarcerated veterans by race\/ethnicity. Social Psychiatry and Psychiatric Epidemiology, 48(11), 1777\u20131786.","journal-title":"Social Psychiatry and Psychiatric Epidemiology"},{"issue":"2","key":"336_CR43","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1001\/jamapsychiatry.2018.3126","volume":"76","author":"ND Volkow","year":"2019","unstructured":"Volkow, N. D., Jones, E. B., Einstein, E. B., & Wargo, E. M. (2019). Prevention and treatment of opioid misuse and addiction: A review. JAMA Psychiatry, 76(2), 208\u2013216. https:\/\/doi.org\/10.1001\/jamapsychiatry.2018.3126","journal-title":"JAMA Psychiatry"},{"key":"336_CR44","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-016-3845-5","author":"TN Winkelman","year":"2016","unstructured":"Winkelman, T. N., Kieffer, E. C., Goold, S. D., Morenoff, J. D., Cross, K., & Ayanian, J. Z. (2016). Health insurance trends and access to behavioral healthcare among justice-involved individuals-United States, 2008\u20132014. Journal of General Internal Medicine. https:\/\/doi.org\/10.1007\/s11606-016-3845-5","journal-title":"Journal of General Internal Medicine"},{"issue":"2","key":"336_CR45","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/08897077.2018.1452327","volume":"39","author":"JJ Wyse","year":"2018","unstructured":"Wyse, J. J., Gordon, A. J., Dobscha, S. K., Morasco, B. J., Tiffany, E., Drexler, K., Sandbrink, F., & Lovejoy, T. I. (2018). Medications for opioid use disorder in the department of veterans affairs (VA) health care system: Historical perspective, lessons learned, and next steps. Substance Abuse, 39(2), 139\u2013144. https:\/\/doi.org\/10.1080\/08897077.2018.1452327","journal-title":"Substance Abuse"}],"container-title":["Health &amp; Justice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40352-025-00336-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40352-025-00336-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40352-025-00336-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T12:36:21Z","timestamp":1745930181000},"score":1,"resource":{"primary":{"URL":"https:\/\/healthandjusticejournal.biomedcentral.com\/articles\/10.1186\/s40352-025-00336-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["336"],"URL":"https:\/\/doi.org\/10.1186\/s40352-025-00336-6","relation":{},"ISSN":["2194-7899"],"issn-type":[{"value":"2194-7899","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"27 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Stanford University Institutional Review Board (#44494) and the VA Palo Alto Research & Development Committee in accordance with the Declaration of Helsinki. All data reported in this manuscript were approved under a waiver of consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28"}}